4//SEC Filing
Coyne Christine 4
Accession 0000950170-25-093872
CIK 0001659323other
Filed
Jul 2, 8:00 PM ET
Accepted
Jul 3, 4:16 PM ET
Size
5.6 KB
Accession
0000950170-25-093872
Insider Transaction Report
Form 4
Coyne Christine
Chief Commercial Officer
Transactions
- Award
Share Option (Right to Buy)
2025-07-01+200,000→ 200,000 totalExercise: $0.97Exp: 2035-06-30→ Ordinary Shares (200,000 underlying)
Footnotes (1)
- [F1]The shares underlying this option shall vest at a rate of twenty-five percent of the total number of shares on the one-year anniversary of July 1, 2025 and the remaining 75% will vest in equal monthly installments thereafter until July 1, 2029, subject to the Reporting Person providing continuous service to the Issuer on each relevant vesting date.
Documents
Issuer
Iterum Therapeutics plc
CIK 0001659323
Entity typeother
Related Parties
1- filerCIK 0001861840
Filing Metadata
- Form type
- 4
- Filed
- Jul 2, 8:00 PM ET
- Accepted
- Jul 3, 4:16 PM ET
- Size
- 5.6 KB